Analysts' recommendations: Avinger, Inc.

23-04-21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
22-05-11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
22-03-18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
21-06-29	Avinger : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

More recommendations

Managers and Directors: Avinger, Inc.

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	2024-08-04

More insiders

Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq 16:00:00 2025-02-14 EST			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.38M 2.25M 2.04M 3.84M 260M 3.86M 26.96M 10.41M 133M 10.16M 9.94M 426M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.28M 10.67M 9.68M 18.17M 1.23B 18.28M 128M 49.33M 628M 48.16M 47.12M 2.02B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
25-02-10	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
25-02-10	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
25-02-10	Avinger, Inc. Announces Executive Changes	CI
24-12-24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24-12-24	US Futures Tread Water Ahead of Holiday Break	MT
24-12-23	Iberdrola Completes Merger with Avangrid	MT
24-11-07	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-11-07	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
24-11-07	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
24-11-07	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
24-10-04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

25-01-02	Avinger : Private Placement Form 8 K	PU
24-11-07	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
24-11-07	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
24-11-07	Avinger: Q3 Earnings Snapshot	AQ
24-10-25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Avinger, Inc. Stock

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news: Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/23/25	Himanshu Patel	Sell	Founder	2,215	0.0669%
1/23/25	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%
1/23/25	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-92.77%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	+3.39%	+3.22%	-26.64%	+1.72%	12.89B
IRAY GROUP	-4.64%	-5.43%	+4.69%	-4.86%	3.96B
SONOSCAPE MEDICAL CORP.	+0.16%	-2.03%	-43.25%	-60.45%	1.21B
IRADIMED CORPORATION	+1.05%	+5.09%	+23.32%	+92.36%	1.11B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-0.67%	-0.67%	-41.23%	-43.51%	1.09B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-0.49%	-0.56%	-34.82%	-	1.03B
NINGBO JANSEN SUPERCONDUCTING TECHNOLOGIES CO., LTD.	-3.21%	-3.06%	-	-	964M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-6.72%	-9.32%	+20.89%	+79.75%	461M
CAPSOVISION, INC.	+4.06%	+11.79%	+51.09%	-	346M
Average	-2.78%	+1.98%	-5.10%	-3.97%	2.31B
Weighted average by Cap.	+0.89%	+0.81%	-18.31%	+1.02%

	2022	2023
Net sales	8.27M 7.28M 6.88M 6.24M 11.72M 794M 11.79M 82.38M 31.82M 405M 31.06M 30.39M 1.3B	7.65M 6.73M 6.36M 5.77M 10.84M 735M 10.9M 76.2M 29.43M 375M 28.73M 28.11M 1.2B
Net income	-17.62M -15.5M -14.66M -13.29M -24.97M -1.69B -25.11M -175M -67.77M -863M -66.16M -64.73M -2.77B	-18.32M -16.11M -15.24M -13.82M -25.95M -1.76B -26.1M -182M -70.46M -897M -68.78M -67.29M -2.88B
Net Debt	1.76M 1.54M 1.46M 1.32M 2.49M 169M 2.5M 17.49M 6.75M 86.01M 6.59M 6.45M 276M	10.12M 8.9M 8.42M 7.63M 14.34M 971M 14.42M 101M 38.92M 496M 37.99M 37.17M 1.59B

3 years	0.36	6.55
5 years	0.36	288.9
10 years	0.36	618,002.47